Blog - Page 1838 of 5768

ThursdayMar 05, 2020 2:06 pm

QualityStocksNewsBreaks – Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) Announces Filing of Financial Statements, Provides Status Update

Wonderfilm Media (TSX.V: WNDR) (OTCQB: WDRFF) on Wednesday announced filing of its audited annual consolidated financial statements, management's discussion and analysis and associated officer certificates for its financial year ended June 30, 2019, the interim financial statements, management's discussion and analysis and associated officer certificates for the company's three month period ended September 30, 2019, and the interim financial statements, management's discussion and analysis and associated officer certificates for the company's three and six month periods ended December 31, 2019. Wonderfilm is now up to date with its continuous obligations under National Instrument 51-102 - Continuous Disclosure Obligations and expects,…

ThursdayMar 05, 2020 1:25 pm

QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Enters Financing Agreement with B. Riley Financial, Inc. Affiliate

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced its entry into a secured term loan with an affiliate of B. Riley Financial, Inc. ("B. Riley"), a diversified financial services company which provides comprehensive business advisory and capital markets solutions through its subsidiaries. “We are excited to partner with B. Riley. The team is experienced and will help us take the next steps in executing our plan,” SRAX Founder and CEO Christopher Miglino said in the news release. “This financing will help fuel growth as both BIGtoken.com and SRAXir.com are gaining traction in their goals…

ThursdayMar 05, 2020 1:19 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Successful Processing of DehydraTECH(TM)-Enabled Nanoemulsion for CBD Beverages

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, on Wednesday announced successful processing of its first DehydraTECH(TM)-enabled liquid nanoemulsion for cannabidiol ("CBD") beverages for one of its licensed clients. Per the update, Lexaria's client expects to soon begin distribution of its line of CBD beverages in select stores across the U.S. Emulsified DehydraTECH processing is an additional service Lexaria can now provide to qualifying clients wanting to formulate best in class ready-to-drink beverages containing CBD. As referenced in a February 13 press release, Lexaria recently added this additional capability to its powder production facility.…

ThursdayMar 05, 2020 12:25 pm

ChineseInvestors.com Inc. (CIIX) Launches Media Campaign Raising Awareness of CBD-Oil Benefits

CEO announces that company will sponsor infomercials touting benefits of CBD oil sold through CBD Biotech Co. subsidiary CBD-oil awareness campaign consists of China AM radio infomercial, WeChat group infomercial and New York radio infomercial CIIX planning to expand CBD product offerings in China ChineseInvestors.com Inc. (OTCQB: CIIX) CEO Warren Wang announced during a MoneyTV interview that CIIX is launching a media campaign to raise awareness of the benefits of CBD oil (http://ibn.fm/PqQCy). The multimedia campaign consists of three infomercials: one aired on AM radio in China, one posted on WeChat and one aired on New York radio. “A lot of…

ThursdayMar 05, 2020 12:21 pm

QualityStocksNewsBreaks – Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Enters Cooperation Agreement with Chinese Metals Supplier

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) today announced its entry into a non-binding cooperation agreement with Hunan Shijiyintian New Material Co., Ltd, an 100% wholly owned subsidiary of Hunan Jinxin New Material Co., Ltd. ("Hunan Jinxin"). Bolt Metals and Hunan Jinxin will immediately commence negotiations with the intention of entering into one or more definitive binding agreements definitive agreement, subject to further due diligence to be completed between the parties. According to the update, it is anticipated that there will be two primary components of a definitive agreement, including a preliminary offtake and investment. “While recent market…

ThursdayMar 05, 2020 12:09 pm

QualityStocksNewsBreaks – MCTC Holdings, Inc. (MCTC) Enters Sales and Distribution Agreement with Sinister CBD LLC for Hemp You Can Feel(TM) Coffee Product Line

MCTC Holdings (OTC: MCTC), a cannabinoid and hemp extract science forward company developing infusion and delivery technologies, today announced its receipt of an initial order from Sinister CBD, LLC for sales and distribution of its Hemp You Can Feel(TM) Coffee product line. Hemp You Can Feel(TM), MCTC’s new product line based on its patent-pending infusion technologies, is the industry's first 100% natural hemp extract and CBD coffee to be shipped in 100% compostable single-serving coffee pods. Under the agreement, MCTC will private label its coffee products under the Sinister CBD brand name and other brands to be included in subsequent…

ThursdayMar 05, 2020 11:39 am

Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE) Aims to Become Major Player on Expanding EV Supply Chain in Indonesia, China

Trends in environmental consciousness continue to shift global demand away from carbon-based cars toward electric vehicles Bolt Metals Corp. rebrands marketing strategy as part of plan to become the leading international player in the electric vehicle battery metal sector The company’s Cyclops drilling project is aligned perfectly to fit the supply chain criteria for the electric vehicle sector in Asia A global shift away from carbon-based cars and trucks is pumping billions of dollars into battery-powered electric vehicle (EV) research and related development projects. Bolt Metals Corp. (CSE: BOLT) (OTCQB: PCRCF) (XFRA: NXFE), an exploration company focused on the acquisition and development of…

ThursdayMar 05, 2020 11:15 am

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) to Exhibit at HIMSS 2020 Global Health Conference & Exhibition

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform that enables drug availability, care services and price transparency for both pharmacists and consumers, today announced that it will exhibit at HIMSS 2020. The event, which will draw over 45,000 healthcare professionals, is slated to take place at the Orange County Convention center in Orlando, Florida from March 9-13. Trxade’s booth will be located in Exhibit Hall E, Booth (#7273), Kiosk (#13). Members from the company’s leadership team will be present and provide detailed DEMO and information on products including: DelivMeds and Bonum Health, demonstrating the latest advances…

ThursdayMar 05, 2020 11:10 am

QualityStocksNewsBreaks – Genprex, Inc.’s (NASDAQ: GNPX) Lead Researcher Behind its Diabetes Gene Therapy Featured in New Video Interview

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing treatments for cancer and other serious diseases, today announced that Dr. George Gittes, the lead researcher and Harvard graduate that developed Genprex’s new potentially curative diabetes gene therapy, was featured in a video interview discussing the therapy. According to the update, Dr. Gittes joined one of Proactive’s broadcast journalists to provide an overview of the gene therapy, how it works, how it may have the potential to help treat type 1 and type 2 diabetes, as well as next steps to move the gene therapy to the clinic. “We…

ThursdayMar 05, 2020 11:04 am

Predictive Oncology Inc. (NASDAQ: POAI) Signs LOI for Acquisition of Leading Biomedical Analytics Company, Novel Drug-Discovery Platform

POAI’s planned acquisition of Quantitative Medicine (QM) will revolutionize the way precision therapies are developed QM’s CoRE platform predicts main effects of drugs on target molecules that mediate disease Synergies created by acquisition support POAI’s efforts to accelerate the commercialization of its AI-driven predictive model services Predictive Oncology Inc. (NASDAQ: POAI) has announced the latest development in its mission to become the leader in the cancer precision-medicine field. In line with its focus on applying artificial intelligence (AI) to personalized medicine and drug discovery, POAI has signed a signed a Letter of Intent to acquire Quantitative Medicine (QM), a leading…

Site Search

Company Search